Between Dec. 14, 2020, and Mar. 5, 2021, 31,079 reports of adverse events were submitted to VAERS, including 1,524 deaths, 5,507 serious injuries and 390 reports of Bell’s Palsy.
Data released today by the Centers for Disease Control and Prevention (CDC) on the number of injuries and deaths reported to the Vaccine Adverse Event Reporting System (VAERS) following COVID vaccines remain consistent with previous weeks, with the exception of a 31% spike in reports of Bell’s Palsy.
Every Friday, VAERS makes public all vaccine injury reports received by the system as of Friday of the previous week. Today’s data show that between Dec. 14, 2020, and March 5, a total of 31,079 total adverse events were reported to VAERS, including 1,524 deaths — an increase of 259 over the previous 7 days — and 5,507 serious injuries, up 1,083 over the same time period.In the U.S., 85.01 million COVID vaccine doses had been administered as of March 5.
VAERS is the primary mechanism for reporting adverse vaccine reactions in the U.S. Reports submitted to VAERS require further investigation before a causal relationship can be confirmed.
This week’s 31% increase in reports of Bell’s Palsy marks a break with past trends. Otherwise, today’s data reflect trends that have emerged since The Defender first began tracking VAERS reports related to COVID vaccines.
This week’s VAERS data show:
Of the 1,524 deaths reported as of March 6, 30% occurred within 48 hours of vaccination, and 46% occurred in people who became ill within 48 hours of being vaccinated.
Nineteen percent of deaths were related to cardiac disorders.
Fifty-three percent of those who died were male, 45% were female and the remaining death reports did not include gender of the deceased.
The average age of those who died was 77.9 and the youngest death confirmed was a 23-year-old.
As of March 5, 265 pregnant women had reported adverse events related to COVID vaccines, including 85 reports of miscarriage or premature birth. None of the COVID vaccines approved for Emergency Use Authorization (EUA) have been tested for safety or efficacy in pregnant women.
There were 1,689 reports of anaphylaxis, with 59% of cases attributed to the Pfizer-Bio-N-Tech vaccine and 41% to Moderna.